{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:49Z","timestamp":1783641649632,"version":"3.55.0"},"reference-count":143,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"vor","delay-in-days":396,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.micinf.2020.09.004","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T11:15:06Z","timestamp":1600514106000},"page":"515-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system"],"prefix":"10.1016","volume":"22","author":[{"given":"Nina Mar\u00ed G.P.","family":"de Queiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio V.","family":"Marinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo A.","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana C.C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Jane","family":"Homan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana T.Q.","family":"de Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio C.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2020.09.004_bib1","author":"WHO"},{"key":"10.1016\/j.micinf.2020.09.004_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.micinf.2020.09.004_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib4","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1128\/JVI.02501-05","article-title":"Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex","volume":"80","author":"Snijder","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib5","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1128\/JVI.79.9.5288-5295.2005","article-title":"Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus","volume":"79","author":"Hussain","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000896","article-title":"Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing","volume":"6","author":"Eckerle","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2020.09.004_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003565","article-title":"Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics","volume":"9","author":"Smith","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2020.09.004_bib8","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1128\/JVI.01700-12","article-title":"Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA","volume":"86","author":"Tanaka","year":"2012","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib9","doi-asserted-by":"crossref","first-page":"E4251","DOI":"10.1073\/pnas.1618310114","article-title":"Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages","volume":"114","author":"Deng","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.09.004_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virusres.2019.03.005","article-title":"PEDV nsp16 negatively regulates\u00a0innate immunity to promote viral proliferation","volume":"265","author":"Shi","year":"2019","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2020.09.004_bib11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.09.004_bib12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.09.004_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib14","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","article-title":"Coronaviruses post-SARS: update on replication and pathogenesis","volume":"7","author":"Perlman","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.micinf.2020.09.004_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.tim.2016.03.003","article-title":"Epidemiology, genetic recombination, and pathogenesis of coronaviruses","volume":"24","author":"Su","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.micinf.2020.09.004_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.09.004_bib17","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","article-title":"Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.09.004_bib18","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/infdis\/jit504","article-title":"Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis","volume":"209","author":"Zhou","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2020.09.004_bib19","doi-asserted-by":"crossref","first-page":"8692","DOI":"10.1128\/JVI.00527-07","article-title":"Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome","volume":"81","author":"Cameron","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.09.004_bib21","first-page":"12","article-title":"Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV","author":"Xu","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.09.004_bib22","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib24","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1089\/vim.2016.0178","article-title":"Recognition of viral RNA by pattern recognition receptors in the induction of innate immunity and excessive inflammation during respiratory viral infections","volume":"30","author":"Okamoto","year":"2017","journal-title":"Viral Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib25","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/v11100961","article-title":"Viral innate immune evasion and the pathogenesis of emerging RNA virus infections","volume":"11","author":"Nelemans","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.09.004_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.chom.2016.01.006","article-title":"The evolution of antiviral defense systems","volume":"19","author":"tenOever","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micinf.2020.09.004_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00638-15","article-title":"Toll-like receptor 3 signaling via TRIF contributes to a protective innate immune response to severe acute respiratory syndrome coronavirus infection","volume":"6","author":"Totura","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.micinf.2020.09.004_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000240","article-title":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV","volume":"4","author":"Sheahan","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2020.09.004_bib29","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.micinf.2020.09.004_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2172-10-35","article-title":"Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells","volume":"10","author":"Law","year":"2009","journal-title":"BMC Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib31","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1371\/journal.pbio.0060226","article-title":"SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum","volume":"6","author":"Knoops","year":"2008","journal-title":"PLoS Biol"},{"key":"10.1016\/j.micinf.2020.09.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/a0dde376-2eb1-4ce3-8887-d29f5ba6f162","article-title":"In\u00a0vitro reconstitution of SARS-coronavirus mRNA cap methylation","volume":"6","author":"Bouvet","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2020.09.004_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11262-010-0544-x","article-title":"SARS-CoV nucleocapsid protein antagonizes IFN-beta response by targeting initial step of IFN-beta induction pathway, and its C-terminal region is critical for the antagonism","volume":"42","author":"Lu","year":"2011","journal-title":"Virus Gene"},{"key":"10.1016\/j.micinf.2020.09.004_bib34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/JVI.01782-06","article-title":"Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists","volume":"81","author":"Kopecky-Bromberg","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib35","doi-asserted-by":"crossref","first-page":"e5466","DOI":"10.1371\/journal.pone.0005466","article-title":"MAVS-mediated apoptosis and its inhibition by viral proteins","volume":"4","author":"Lei","year":"2009","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2020.09.004_bib36","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.micinf.2020.09.004_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.20499","article-title":"Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals","volume":"78","author":"Zhang","year":"2006","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib38","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/cid\/ciy595","article-title":"Immune responses to middle east respiratory syndrome coronavirus during the acute and convalescent phases of human infection","volume":"68","author":"Shin","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.micinf.2020.09.004_bib39","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.181.8.5490","article-title":"T\u00a0cell responses to whole SARS coronavirus in humans","volume":"181","author":"Li","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib40","doi-asserted-by":"crossref","first-page":"11034","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib41","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrmicro2090","article-title":"The spike protein of SARS-CoV-a target for vaccine and therapeutic development","volume":"7","author":"Du","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.micinf.2020.09.004_bib42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2020.09.004_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fimmu.2014.00331","article-title":"Mucosal resident memory CD4 T cells in protection and immunopathology","volume":"5","author":"Turner","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4(+) T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib45","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1099\/vir.0.82839-0","article-title":"Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen","volume":"88","author":"Yang","year":"2007","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib46","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","article-title":"Airway memory CD4(+) T cells mediate protective immunity against emerging respiratory coronaviruses","volume":"44","author":"Zhao","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.micinf.2020.09.004_bib47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.706","article-title":"Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential","volume":"22","author":"Coughlin","year":"2012","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib48","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.virol.2014.02.005","article-title":"Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus","volume":"454\u2013455","author":"Yasui","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.09.004_bib49","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib50","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.4049\/jimmunol.0903490","article-title":"Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study","volume":"186","author":"Tang","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41423-020-0402-2","article-title":"Functional exhaustion of antiviral lymphocytes in COVID-19 patients","volume":"17","author":"Zheng","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib53","series-title":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China. F1000Res","first-page":"72","volume":"9","author":"Kruse","year":"2020"},{"key":"10.1016\/j.micinf.2020.09.004_bib54","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1073\/pnas.0409065102","article-title":"Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses","volume":"102","author":"Yang","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.09.004_bib55","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","article-title":"Immunodominant SARS\u00a0coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates","volume":"2","author":"Wang","year":"2016","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.micinf.2020.09.004_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.micinf.2020.09.004_bib57","article-title":"Functional assessment of cell entry and receptor usage for lineage B beta-coronaviruses, including 2019-nCoV","author":"Letko","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.micinf.2020.09.004_bib58","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41594-019-0233-y","article-title":"Structural basis for human coronavirus attachment to sialic acid receptors","volume":"26","author":"Tortorici","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.micinf.2020.09.004_bib59","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.09.004_bib60","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fimmu.2020.01022","article-title":"Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib61","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nsmb1123","article-title":"Architecture of the SARS coronavirus prefusion spike","volume":"13","author":"Beniac","year":"2006","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.micinf.2020.09.004_bib62","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.abb9983","article-title":"Site-specific glycan analysis of the SARS-CoV-2 spike","volume":"369","author":"Watanabe","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.09.004_bib63","doi-asserted-by":"crossref","first-page":"15216","DOI":"10.1038\/ncomms15216","article-title":"Crystal structure of the receptor binding domain of the spike glycoprotein of human betacoronavirus HKU1","volume":"8","author":"Ou","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2020.09.004_bib64","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2020.09.004_bib65","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.bbagen.2019.05.012","article-title":"Exploitation of glycosylation in enveloped virus pathobiology","volume":"1863","author":"Watanabe","year":"2019","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.micinf.2020.09.004_bib66","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jmv.25754","article-title":"From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and nonstructural genes","volume":"92","author":"Kandeel","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/v12030254","article-title":"Preliminary identification of potential vaccine targets for the COVID-19 coronavirus (SARS-CoV-2) based on SARS-CoV immunological studies","volume":"12","author":"Ahmed","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.09.004_bib68","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.09.004_bib69","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.09.004_bib70","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.REV120.013930","article-title":"The molecular virology of Coronaviruses","author":"Hartenian","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2020.09.004_bib71","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/v12050497","article-title":"The SARS-CoV-2 exerts a distinctive strategy for interacting with the ACE2 human receptor","volume":"12","author":"Brielle","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.09.004_bib72","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2020.09.004_bib73","first-page":"1","article-title":"Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor","author":"Veeramachaneni","year":"2020","journal-title":"J\u00a0Biomol Struct Dyn"},{"key":"10.1016\/j.micinf.2020.09.004_bib74","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1745-7580-6-8","article-title":"An integrated approach to epitope analysis II: a system for proteomic-scale prediction of immunological characteristics","volume":"6","author":"Bremel","year":"2010","journal-title":"ImmunomeRes"},{"key":"10.1016\/j.micinf.2020.09.004_bib75","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMp2005630","article-title":"Developing Covid-19 vaccines at pandemic speed","volume":"382","author":"Lurie","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib76","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/d41586-020-01221-y","article-title":"The race for coronavirus vaccines: a graphical guide","volume":"580","author":"Callaway","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib77","author":"WHO"},{"key":"10.1016\/j.micinf.2020.09.004_bib78","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.micinf.2020.09.004_bib79","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/vaccines8020153","article-title":"Progress and prospects on vaccine development against SARS-CoV-2","volume":"8","author":"Zhang","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micinf.2020.09.004_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.09.004_bib81","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.09.004_bib82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.virol.2008.03.002","article-title":"SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector","volume":"376","author":"Kapadia","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.09.004_bib83","article-title":"ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques","author":"van Doremalen","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.micinf.2020.09.004_bib84","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(16)32617-4","article-title":"Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"389","author":"Zhu","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.09.004_bib85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/vaccines1030225","article-title":"Vector design for improved DNA vaccine efficacy, safety and production","volume":"1","author":"Williams","year":"2013","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micinf.2020.09.004_bib86","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","article-title":"New vaccine technologies to combat outbreak situations","volume":"9","author":"Rauch","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib87","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines7020037","article-title":"A\u00a0comparison of plasmid DNA and mRNA as vaccine technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micinf.2020.09.004_bib88","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/17425247.2016.1121990","article-title":"Clinical potential of electroporation for gene therapy and DNA vaccine delivery","volume":"13","author":"Lambricht","year":"2016","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.micinf.2020.09.004_bib89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.micinf.2020.09.004_bib90","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.vaccine.2004.09.001","article-title":"TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines","volume":"23","author":"Tudor","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.09.004_bib91","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature06537","article-title":"TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines","volume":"451","author":"Ishii","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib92","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.4049\/jimmunol.0803935","article-title":"Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection","volume":"184","author":"Rottembourg","year":"2010","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib93","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nature08476","article-title":"STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity","volume":"461","author":"Ishikawa","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib94","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4049\/jimmunol.1501836","article-title":"A\u00a0cGAS-independent STING\/IRF7 pathway mediates the immunogenicity of DNA vaccines","volume":"196","author":"Suschak","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib95","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2020.09.004_bib96","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/iub.1625","article-title":"RNA sensors of the innate immune system and their detection of pathogens","volume":"69","author":"Chen","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.micinf.2020.09.004_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-016-1111-6","article-title":"Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response","volume":"15","author":"Edwards","year":"2017","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.12505","article-title":"CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes","volume":"146","author":"Lazzaro","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/j.micinf.2020.09.004_bib99","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.09.004_bib100","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/eji.1830230749","article-title":"Induction of virus-specific cytotoxic T lymphocytes in\u00a0vivo by liposome-entrapped mRNA","volume":"23","author":"Martinon","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib101","first-page":"1","article-title":"Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic","volume":"38","author":"Prompetchara","year":"2020","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib102","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/s41467-020-16505-0","article-title":"Immunogenicity of a DNA vaccine candidate for COVID-19","volume":"11","author":"Smith","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2020.09.004_bib103","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41423-020-0377-z","article-title":"Epitopes for a 2019-nCoV vaccine","volume":"17","author":"Lucchese","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib104","series-title":"In silico identification of vaccine targets for 2019-nCoV. F1000Res","first-page":"145","volume":"9","author":"Lee","year":"2020"},{"key":"10.1016\/j.micinf.2020.09.004_bib105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1749-6632.1989.tb27366.x","article-title":"New strategies for leprosy and tuberculosis and for development of bacillus Calmette-Guerin into a multivaccine vehicle","volume":"569","author":"Bloom","year":"1989","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.micinf.2020.09.004_bib106","first-page":"93","article-title":"Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety","volume":"68","author":"Milstien","year":"1990","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.micinf.2020.09.004_bib107","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1054\/tuld.1999.0206","article-title":"Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree","volume":"79","author":"Oettinger","year":"1999","journal-title":"Tuber Lung Dis"},{"key":"10.1016\/j.micinf.2020.09.004_bib108","author":"WHO"},{"key":"10.1016\/j.micinf.2020.09.004_bib109","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.4049\/jimmunol.158.4.1949","article-title":"Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin","volume":"158","author":"Ravn","year":"1997","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib110","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.172.6.3491","article-title":"Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes","volume":"172","author":"van Faassen","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib111","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/S0264-410X(01)00155-4","article-title":"Recombinant BCG vaccines","volume":"19","author":"Ohara","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.09.004_bib112","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/351479a0","article-title":"Humoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines","volume":"351","author":"Aldovini","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib113","doi-asserted-by":"crossref","first-page":"12871","DOI":"10.1128\/JVI.79.20.12871-12879.2005","article-title":"Priming-boosting vaccination with recombinant Mycobacterium bovis bacillus Calmette-Guerin and a nonreplicating vaccinia virus recombinant leads to long-lasting and effective immunity","volume":"79","author":"Ami","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.09.004_bib114","first-page":"574591","article-title":"Mycobacterium bovis Bacille Calmette-Guerin as a vaccine vector for global infectious disease control","volume":"2011","author":"Matsuo","year":"2011","journal-title":"Tuberc Res Treat"},{"key":"10.1016\/j.micinf.2020.09.004_bib115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/vaccines7030078","article-title":"Recombinant BCG expressing HTI prime and recombinant ChAdOx1 boost is safe and elicits HIV-1-specific T-cell responses in BALB\/c Mice","volume":"7","author":"Kilpelainen","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micinf.2020.09.004_bib116","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/351456a0","article-title":"New use of BCG for recombinant vaccines","volume":"351","author":"Stover","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.09.004_bib117","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1084\/jem.180.6.2277","article-title":"Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guerin vaccines expressing pneumococcal surface protein A","volume":"180","author":"Langermann","year":"1994","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib118","first-page":"229","article-title":"Efficacy and safety of live recombinant BCG vaccines","volume":"84","author":"Hanson","year":"1995","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.micinf.2020.09.004_bib119","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1128\/IAI.68.9.4877-4883.2000","article-title":"Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice","volume":"68","author":"Nascimento","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2020.09.004_bib120","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1128\/IAI.72.6.3336-3343.2004","article-title":"Recombinant Mycobacterium bovis BCG expressing the Sm14 antigen of Schistosoma mansoni protects mice from cercarial challenge","volume":"72","author":"Varaldo","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.micinf.2020.09.004_bib121","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI24617","article-title":"Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guerin mutants that secrete listeriolysin","volume":"115","author":"Grode","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.micinf.2020.09.004_bib122","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1128\/AEM.03677-15","article-title":"New recombinant Mycobacterium bovis BCG expression vectors: improving genetic control over mycobacterial promoters","volume":"82","author":"Kanno","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.micinf.2020.09.004_bib123","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.micinf.2020.09.004_bib124","doi-asserted-by":"crossref","first-page":"i5170","DOI":"10.1136\/bmj.i5170","article-title":"Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review","volume":"355","author":"Higgins","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.micinf.2020.09.004_bib125","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/fmb-2018-0026","article-title":"Heterologous effects of infant BCG vaccination: potential mechanisms of immunity","volume":"13","author":"Butkeviciute","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.micinf.2020.09.004_bib126","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M.\u00a0tuberculosis infection with H4:IC31 vaccine or BCG revaccination","volume":"379","author":"Nemes","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib127","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.micinf.2020.09.004_bib128","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micinf.2020.09.004_bib129","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.09.004_bib130","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.micinf.2020.09.004_bib131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micinf.2020.09.004_bib132","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/all.14345","article-title":"Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?","volume":"75","author":"Gursel","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.micinf.2020.09.004_bib133","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012661","article-title":"Is BCG vaccination causally related to reduced COVID-19 mortality?","volume":"12","author":"Miyasaka","year":"2020","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.micinf.2020.09.004_bib134","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41577-020-0337-y","article-title":"BCG-induced trained immunity: can it offer protection against COVID-19?","volume":"20","author":"O\u2019Neill","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2020.09.004_bib135","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cell.2020.04.042","article-title":"Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection","volume":"181","author":"Netea","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2020.09.004_bib136","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","author":"Miller","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.micinf.2020.09.004_bib137","article-title":"COVID-19: a model correlating BCG vaccination to protection from mortality implicates trained immunity","author":"Green","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.micinf.2020.09.004_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1463","article-title":"Mandated Bacillus Calmette-Gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19","author":"Berg","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.micinf.2020.09.004_bib139","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1001\/jama.2020.8189","article-title":"SARS-CoV-2 rates in BCG-vaccinated and unvaccinated young adults","volume":"323","author":"Hamiel","year":"2020","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.micinf.2020.09.004_bib140","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cytogfr.2014.08.004","article-title":"Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection","volume":"25","author":"Maringer","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.micinf.2020.09.004_bib141","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s13238-014-0026-3","article-title":"SARS coronavirus papain-like protease inhibits the type I interferon signaling pathway through interaction with the STING-TRAF3-TBK1 complex","volume":"5","author":"Chen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.micinf.2020.09.004_bib142","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.virol.2019.01.006","article-title":"The STING agonist 5,6-dimethylxanthenone-4-acetic acid (DMXAA) stimulates an antiviral state and protects mice against herpes simplex virus-induced neurological disease","volume":"529","author":"Ceron","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.09.004_bib143","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645792030157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S128645792030157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:38:40Z","timestamp":1761143920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S128645792030157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S128645792030157X"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2020.09.004","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2020.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}